⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OKYO News
OKYO Pharma Limited Ordinary Shares
OKYO Pharma to Participate in 2026 Jefferies Global Healthcare Conference in London
globenewswire.com
OKYO
OKYO Pharma to Present at the Stifel 2026 Healthcare Conference
globenewswire.com
OKYO
OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain
globenewswire.com
OKYO
OKYO Pharma Presents and Participates at Upcoming Ophthalmic Scientific Conferences
globenewswire.com
OKYO
OKYO Pharma to Present at Ophthalmology Futures European Forum and iNovation Day at ESCRS 2026
globenewswire.com
OKYO
OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference
globenewswire.com
OKYO
Neuropathic Ocular Pain (NOP) Market Insights, Epidemiology & Forecast 2026-2036: Urcosimod Emerges as a Promising Targeted NOP Therapy
globenewswire.com
OKYO
OKYO Pharma Announces Purchase of Shares by Chief Scientific Officer
globenewswire.com
OKYO
OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026
globenewswire.com
OKYO
OKYO Pharma Announces Purchase of Shares by Director
globenewswire.com
OKYO